News

Cambrex Corporation announced that it had completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA. The 6,000 sq. ft.…
Read More...

Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 50mg injection of Decitabine, which…
Read More...

I-Mab Biopharma, a clinical stage biopharmaceutical company exclusively focused on the development of potential first-in-class and best-in-class biologics in immuno-oncology and…
Read More...

LEO Pharma A/S announced an expansion of the two companies' partnership agreement (signed in 2017) to further include antibodies from LEO Pharma's pipeline with the aim of achieving…
Read More...

The Vifor Pharma Group and Akebia Therapeutics announced that the companies have amended the terms of their licence agreement to sell vadadustat to Fresenius Medical Care North America…
Read More...

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and…
Read More...

Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk…
Read More...

Concerto HealthAI announced that they have entered into a collaboration with Pfizer to advance work in Precision Oncology using Concerto HealthAI’s eurekaHealthTM platform, artificial…
Read More...

Eurofins Discovery announced its premier offering for integrated drug discovery services. Eurofins Discovery has successfully collaborated with clients in integrated drug discovery…
Read More...

Sun Pharmaceutical Industries Ltd. announced that INFUGEM™ (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the first…
Read More...

Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B and age-related diseases, announced that it has…
Read More...

Centene Corporation and Washington University School of Medicine in St. Louis announced a partnership to transform and accelerate research into treatments for Alzheimer's disease,…
Read More...

Regeneron Pharmaceuticals and Alnylam Pharmaceuticals announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of…
Read More...

ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC)…
Read More...

Celgene Corporation and Acceleron Pharma Inc. announced that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an erythroid maturation agent, for the…
Read More...

UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North…
Read More...

Novartis announced that there is a legal dispute with Amgen regarding the collaboration agreements in the field of migraine. On April 2, 2019, Amgen issued a notice of termination of…
Read More...

Pfizer announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to expand the indications for IBRANCE (palbociclib) in combination…
Read More...

The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in…
Read More...

Sinovant Sciences and Roivant Sciences announced the launch of Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing innovative cellular therapeutics…
Read More...